Global Health Limited (ASX: GLH) - Share Price
- Current share price for GLH : $0.065
Global Health Limited (GLH), an ASX-listed company, is a provider of Australian digital health solutions, delivering innovative software to connect healthcare providers and consumers. Established in 1985, Global Health brings nearly four decades of experience and is recognised as one of Australia's longest-standing healthcare technology companies.
GLH General Information +
| ASX Code | GLH |
| Website | N/A |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 3 |
| GLH Share Price | $0.065 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.065 |
| GLH Share Price Movement | - ( No change ) |
Prices as at 16:40, 10 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Global Health Limited (GLH) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 1¢ | 0% | 1 Mar 2017 | 9 Mar 2017 | - | - | - |
| Result | 1¢ | 0% | 3 Nov 2016 | 25 Nov 2016 | - | - | - |
See all dividends from Global Health Limited (GLH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Global Health Limited (GLH) price-sensitive announcements
GLH - March-26 QTR Business Activity Report and Appendix 4C
The March-26 Quarter Business Activity Report and Appendix 4C for Global Health Limited fo
Global Health Limited (GLH)
22 Apr 2026 | 9:05 AM
22 Apr 2026 | 9:05 AM
GLH - Global Health Limited HY 2026 Results Update for Investors
Global Health Limited (ASX: GLH) reported its Half-Year (HY) 2026 results, showcasing sign
Global Health Limited (GLH)
25 Mar 2026 | 11:21 AM
25 Mar 2026 | 11:21 AM
GLH - Dec 2025 Appendix 4D and Half Year Accounts
Global Health Limited has reported a consolidated loss of $629,201 for the half year ended
Global Health Limited (GLH)
25 Feb 2026 | 2:40 PM
25 Feb 2026 | 2:40 PM
GLH - Amendment Cover page for Appendix 4C December 25 QTR
Global Health Limited announced an amendment to their Appendix 4C December 2025 Quarterly
Global Health Limited (GLH)
19 Jan 2026 | 10:01 AM
19 Jan 2026 | 10:01 AM
Global Health Limited (GLH) Recent ASX Announcements
GLH Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$0.87 | -$1.50 | -34.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$1.31 | -$2.30 | -68.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$4.16 | -$7.20 | 97.50% | 0.00 | 0.00 | 0.00% | 0.0% |
GLH Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| 4DMedical Limited (4DX) | $2,427M | 0.3304 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Global Health Limited (GLH) | $4M | -0.3407 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $21,983M | 0.3919 | 0.2545 | 0.2962 | 191.1172 | 152.3458 | 117.5334 | 0.26% | 0.33% | 0.44% |
GLH Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Alumootil Mathew Cherian | Executive Director, Managing Director | 28 Jan 2000 |
| Mr Steven Leigh Pynt | Non-Executive Director | 28 Jan 2000 |
| Mr Stuart Grant Smith | Non-Executive Director, Non-Executive Chairman | 25 Sep 2013 |
Global Health Limited (GLH) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 28 Aug 2024 | SMITH, Stuart | Issued | Convertibles | 50,000 | $1.000 | $50,000.000 |
| 28 Aug 2024 | STRANGE, Steven | Issued | Convertibles | 50,000 | $1.000 | $50,000.000 |
| 28 Aug 2024 | CHERIAN, Alumootil | Issued | Convertibles | 50,000 | $1.000 | $50,000.000 |
See all changes in directors' interest & trades for Global Health Limited (GLH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
GLH Management
| Name | Position |
|---|---|
| D Groenveld | Chief Technology Officer |
| Christopher Fernandes | Joint Company Secretary |
| Anara Malabekova | Joint Company Secretary |
GLH Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Global Health Limited (GLH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 24,176,619 (41.27%) | Mathew Cherian |
| 8,587,654 (14.66%) | J P Morgan Nominees Australia Pty Limited |
GLH Calendar of Events
| Date | Event |
|---|---|
| 24 February 2027 | Report (Interim) |
| 26 August 2026 | Report (Annual) |
| 26 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
